Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin. [electronic resource]
Producer: 20050728Description: 1275-82 p. digitalISSN:- 1420-682X
- Animals
- Anthraquinones
- Antineoplastic Agents -- antagonists & inhibitors
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cisplatin -- antagonists & inhibitors
- Dose-Response Relationship, Drug
- Drug Antagonism
- Emodin -- pharmacology
- Enzyme Activation -- drug effects
- Enzyme Inhibitors -- pharmacology
- Extracellular Signal-Regulated MAP Kinases -- antagonists & inhibitors
- Fibrosarcoma -- drug therapy
- Flavonoids -- pharmacology
- Glioma -- drug therapy
- Mice
- Platinum -- chemistry
- Rats
- Structure-Activity Relationship
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.